CD8A and cancer: Thus, a solid and fibrotic TME may inhibit anti-tumor immunity by physically excluding CD8+ T cells and mechano-metabolic programming TAMs, generating an unfavorable metabolic milieu for anti-cancer immunotherapies [155].